Expression of AFP and Rev-Erb A/Rev-Erb B and N-CoR in fetal rat liver, liver injury and liver regeneration

Comparative Hepatology

Volumn 5, Issue , 2006, Pages

  Meier, Volker ^a   Tron, Kyrylo ^a   Batusic, Danko ^a   Elmaouhoub, Abderrahim ^a   Ramadori, Giuliano ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; CARBON TETRACHLORIDE; CELL NUCLEUS RECEPTOR; MESSENGER RNA; N (2 FLUORENYL)ACETAMIDE; TURPENTINE OIL;

ACUTE PHASE RESPONSE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; FETUS; FETUS LIVER; GENE CONTROL; GENE EXPRESSION; GENE EXPRESSION REGULATION; IN VIVO STUDY; LIVER CELL; LIVER DEVELOPMENT; LIVER INJURY; LIVER REGENERATION; MALE; NONHUMAN; NORTHERN BLOTTING; PARTIAL HEPATECTOMY; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR DOWN REGULATION; RNA HYBRIDIZATION; STEM CELL; UPREGULATION;

EID: 33747694396     PISSN: 14765926     EISSN: 14765926     Source Type: Journal    
DOI: 10.1186/1476-5926-5-2     Document Type: Article

References (45)

1. Evarts RP, Nagy P, Marsden E, Thorgeirsson SS: A precursor-product relationship exists between oval cells and hepatocytes in rat liver. Carcinogenesis 1987, 8(11):1737-1740.
2. Kuhlmann WD: Localization of alpha1-fetoprotein and DNA-synthesis in liver cell populations during experimental hepatocarcinogenesis in rats. Int J Cancer 1978, 21(3):368-380.
3. Sell S, Dunsford HA: Evidence for the stem cell origin of hepatocellular carcinoma and cholangiocarcinoma. Am J Pathol 1989, 134(6):1347-1363.
4. Bernier D, Thomassin H, Allard D, Guertin M, Hamel D, Blaquiere M, Beauchemin M, LaRue H, Estable-Puig M, Belanger L: Functional analysis of developmentally regulated chromatin-hypersensitive domains carrying the alpha 1-fetoprotein gene promoter and the albumin/alpha 1-fetoprotein intergenic enhancer. Mol Cell Biol 1993, 13(3):1619-1633.
5. Nahon JL: The regulation of albumin and alpha-fetoprotein gene expression in mammals. Biochimie 1987, 69(5):445-459.
6. Hu KQ, Kyulo NL, Lim N, Elhazin B, Hillebrand DJ, Bock T: Clinical significance of elevated alpha-fetoprotein (AFP) in patients with chronic hepatitis C, but not hepatocellular carcinoma. Am J Gastroenterol 2004, 99(5):860-865.
7. Bayati N, Silverman AL, Gordon SC: Serum alpha-fetoprotein levels and liver histology in patients with chronic hepatitis C. Am J Gastroenterol 1998, 93(12):2452-2456.
8. Johnson PJ: Role of alpha-fetoprotein in the diagnosis and management of hepatocellular carcinoma. J Gastroenterol Hepatol 1999, 14 Suppl:S32-6.
9. Tong MJ, Blatt LM, Kao VW: Surveillance for hepatocellular carcinoma in patients with chronic viral hepatitis in the United States of America. J Gastroenterol Hepatol 2001, 16(5):553-559.
10. Hellerbrand C, Hartmann A, Richter G, Knoll A, Wiest R, Scholmerich J, Lock G: Hepatocellular carcinoma in southern Germany: epidemiological and clinicopathological characteristics and risk factors. Dig Dis 2001, 19(41):345-351.
11. Lemire JM, Fausto N: Multiple alpha-fetoprotein RNAs in adult rat liver: cell type-specific expression and differential regulation. Cancer Res 1991, 51(17):4656-4664.
12. Bisgaard HC, Nagy P, Ton PT, Hu Z, Thorgeirsson SS: Modulation of keratin 14 and alpha-fetoprotein expression during hepatic oval cell proliferation and liver regeneration. J Cell Physiol 1994, 159(3):475-484.
13. Poliard A, Bakkali L, Poiret M, Foiret D, Danan JL: Regulation of the rat alpha-fetoprotein gene expression in liver. Both the promoter region and an enhancer element are liver-specific and negatively modulated by dexamethasone. J Biol Chem 1990, 265(4):2137-2141.
14. Spear BT: Mouse alpha-fetoprotein gene 5′ regulatory elements are required for postnatal regulation by raf and Rif. Mol Cell Biol 1994, 14(10):6497-6505.
15. Jin DK, Vacher J, Feuerman MH: alpha-Fetoprotein gene sequences mediating Afr2 regulation during liver regeneration. Proc Natl Acad Sci U S A 1998, 95(15):8767-8772.
16. Bois-Joyeux B, Chauvet C, Nacer-Cherif H, Bergeret W, Mazure N, Giguere V, Laudet V, Danan JL: Modulation of the far-upstream enhancer of the rat alpha-fetoprotein gene by members of the ROR alpha, Rev-erb alpha, and Rev-erb beta groups of monomeric orphan nuclear receptors. DNA Cell Biol 2000, 19(10):589-599.
17. Giguere V, Tini M, Flock G, Ong E, Evans RM, Otulakowski G: Isoform-specific amino-terminal domains dictate DNA-binding properties of ROR alpha, a novel family of orphan hormone nuclear receptors. Genes Dev 1994, 8(5):538-553.
18. Retnakaran R, Flock G, Giguere V: Identification of RVR, a novel orphan nuclear receptor that acts as a negative transcriptional regulator. Mol Endocrinol 1994, 8(9):1234-1244.
19. Bonnelye E, Vanacker JM, Desbiens X, Begue A, Stehelin D, Laudet V: Rev-erb beta, a new member of the nuclear receptor superfamily, is expressed in the nervous system during chicken development. Cell Growth Differ 1994, 5(12):1357-1365.
20. Forman BM, Chen J, Blumberg B, Kliewer SA, Henshaw R, Ong ES, Evans RM: Cross-talk among ROR alpha 1 and the Rev-erb family of orphan nuclear receptors. Mol Endocrinol 1994, 8(9):1253-1261.
21. Adelmant G, Begue A, Stehelin D, Laudet V: A functional Rev-erb alpha responsive element located in the human Rev-erb alpha promoter mediates a repressing activity. Proc Natl Acad Sci U S A 1996, 93(8):3553-3558.
22. Atkins GB, Hu X, Guenther MG, Rachez C, Freedman LP, Lazar MA: Coactivators for the orphan nuclear receptor RORalpha. Mol Endocrinol 1999, 13(9):1550-1557.
23. Burke LJ, Downes M, Laudet V, Muscat GE: Identification and characterization of a novel corepressor interaction region in RVR and Rev-erbA alpha. Mol Endocrinol 1998, 12(2):248-262.
24. Koibuchi N, Liu Y, Fukuda H, Takeshita A, Yen PM, Chin WW: ROR alpha augments thyroid hormone receptor-mediated transcriptional activation. Endocrinology 1999, 140(3):1356-1364.
25. Bergstrand CG, Czar B: Demonstration of a new protein fraction in serum from the human fetus. Scand J Clin Lab Invest 1956, 8(2):174.
26. Sato Y, Nakata K, Kato Y, Shima M, Ishii N, Koji T, Taketa K, Endo Y, Nagataki S: Early recognition of hepatocellular carcinoma based on altered profiles of alpha-fetoprotein. N Engl J Med 1993, 328(25):1802-1806.
27. Eleftheriou N, Heathcote J, Thomas HC, Sherlock S: Serum alpha-fetoprotein levels in patients with acute and chronic liver disease. Relation to hepatocellular regeneration and development of primary liver cell carcinoma. J Clin Pathol 1977, 30(8):704-708.
28. Alpert E, Feller ER: Alpha-fetoprotein (AFP) in benign liver disease. Evidence that normal liver regeneration does not induce AFP synthesis. Gastroenterology 1978, 74(5 Pt 1):856-858.
29. Demetris AJ, Seaberg EC, Wennerberg A, Ionellie J, Michalopoulos G: Ductular reaction after submassive necrosis in humans. Special emphasis on analysis of ductular hepatocytes. Am J Pathol 1996, 149(2):439-448.
30. Fiel MI, Antonio LB, Nalesnik MA, Thung SN, Gerber MA: Characterization of ductular hepatocytes in primary liver allograft failure. Mod Pathol 1997, 10(4):348-353.
31. Haque S, Haruna Y, Salto K, Nalesnik MA, Atillasoy E, Thung SN, Gerber MA: Identification of bipotential progenitor cells in human liver regeneration. Lab Invest 1996, 75(5):699-705.
32. Fujikawa T, Hirose T, Fujii H, Oe S, Yasuchika K, Azuma H, Yamaoka Y: Purification of adult hepatic progenitor cells using green fluorescent protein (GFP)-transgenic mice and fluorescence-activated cell sorting. J Hepatol 2003, 39(2):162-170.
33. Lowes KN, Croager EJ, Olynyk JK, Abraham LJ, Yeoh GC: Oval cell-mediated liver regeneration: Role of cytokines and growth factors. J Gastroenterol Hepatol 2003, 18(1):4-12.
34. Alison MR, Poulsom R, Forbes SJ: Update on hepatic stem cells. Liver 2001, 21(6):367-373.
35. Tatematsu M, Kaku T, Medline A, Farber E: Intestinal metaplasia as a common option of oval cells in relation to cholangiofibrosis in liver of rats exposed to 2-acetylaminofluorene. Lab Invest 1985, 52(4):354-362.
36. Batusic DS, Cirnica V, Chen Y, Tron K, Hollemann T, Pieler T, Ramadori G: Identification of genes specific to "oval cells" in the rat 2-acetylaminofluorene/partial hepatectomy model. Histochem Cell Biol 2005, 124(3-4):245-260.
37. Matsusaka S, Tsujimura T, Toyosaka A, Nakasho K, Sugihara A, Okamoto E, Uematsu K, Terada N: Role of c-kit receptor tyrosine kinase in development of oval cells in the rat 2-acetylaminofluorene/partial hepatectomy model. Hepatology 1999, 29(3):670-676.
38. Crosby HA, Kelly DA, Strain AJ: Human hepatic stem-like cells isolated using c-kit or CD34 can differentiate into biliary epithelium. Gastroenterology 2001, 120(2):534-544.
39. Yin L, Lynch D, Ilic Z, Sell S: Proliferation and differentiation of ductular progenitor cells and littoral cells during the regeneration of the rat liver to CCI4/2-AAF injury. Histol Histopathol 2002, 17(1):65-81.
40. Yokoi Y, Narnihisa T, Kuroda H, Komatsu I, Miyazaki A, Watanabe S, Usui K: Immunocytochemical detection of desmin in fat-storing cells (Ito cells). Hepatology 1984, 4(4):709-714.
41. Neubauer K, Knittel T, Armbrust T, Ramadori G: Accumulation and cellular localization of fibrinogen/fibrin during short-term and long-term rat liver injury. Gastroenterology 1995, 108(4):1124-1135.
42. Knittel T, Fellmer P, Neubauer K, Kawakami M, Grundmann A, Ramadori G: The complement-activating protease P100 is expressed by hepatocytes and is induced by IL-6 in vitro and during the acute phase reaction in vivo. Lab Invest 1997, 77(3):221-230.
43. Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ: Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 1979, 18(24):5294-5299.
44. Ramadori G, Sipe JD, Colten HR: Expression and regulation of the murine serum amyloid A (SAA) gene in extrahepatic sites. J Immunol 1985, 135(6):3645-3647.
45. Glisin V, Crkvenjakov R, Byus C: Ribonucleic acid isolated by cesium chloride centrifugation. Biochemistry 1974, 13(12):2633-2637.